Study shows advanced genetic testing expands treatment options for many cancer patients.

Research from the London Health Sciences Centre Research Institute, published in The Journal of Molecular Diagnostics, indicates that advanced genetic testing using next-generation sequencing can identify new treatment avenues for nearly one-third of cancer patients. This method uncovers unique tumor DNA changes often missed by standard tests, potentially allowing access to off-label drugs and clinical trials. The findings offer hope for patients with limited conventional treatment choices, broadening personalized medicine approaches in oncology.